HEAL DSpace

Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor cells

DSpace/Manakin Repository

Show simple item record

dc.contributor.author Maratheftis, CI en
dc.contributor.author Bolaraki, PE en
dc.contributor.author Giannouli, S en
dc.contributor.author Kapsogeorgou, EK en
dc.contributor.author Moutsopoulos, HM en
dc.contributor.author Voulgarelis, M en
dc.date.accessioned 2014-03-01T01:55:30Z
dc.date.available 2014-03-01T01:55:30Z
dc.date.issued 2006 en
dc.identifier.issn 0145-2126 en
dc.identifier.uri http://hdl.handle.net/123456789/27769
dc.subject myelodysplastic syndrome en
dc.subject IRF-1 en
dc.subject alternative splicing en
dc.subject hematopoiesis en
dc.subject.classification Oncology en
dc.subject.classification Hematology en
dc.subject.other ACUTE MYELOID-LEUKEMIA en
dc.subject.other TRANSCRIPTION FACTOR IRF-1 en
dc.subject.other SEQUENCE BINDING-PROTEIN en
dc.subject.other NITRIC-OXIDE SYNTHASE en
dc.subject.other GENE en
dc.subject.other EXPRESSION en
dc.subject.other MUTATIONS en
dc.subject.other DIFFERENTIATION en
dc.subject.other ABNORMALITIES en
dc.subject.other INDUCTION en
dc.title Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor cells en
heal.type journalArticle en
heal.language English en
heal.publicationDate 2006 en
heal.abstract Interferon regulatory factor-1 (IRF-1) mRNA expression was examined in specific cell populations (BMMC, CD34(+) and CD71(+)) derived from 45 MDS patients and 20 controls. All the MDS cell populations, presented an identical IRF-1 mRNA expression pattern, characterized by the absence of full-length IRF-1 mRNA and presence of multiple alternative transcripts. The most common deletions involved exons 2 and 3. Two novel truncated IRF-1 protein forms were detected in MDS BMMC. IRF-1-induced iNOS mRNA expression was exclusively detected in BMMC having full-length transcript. The expression of IRF-1 truncated mRNA and protein forms might be a critical event in the development of MDS. (c) 2006 Elsevier Ltd. All rights reserved. en
heal.publisher PERGAMON-ELSEVIER SCIENCE LTD en
heal.journalName LEUKEMIA RESEARCH en
dc.identifier.isi ISI:000239620500020 en
dc.identifier.volume 30 en
dc.identifier.issue 9 en
dc.identifier.spage 1177 en
dc.identifier.epage 1186 en


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record